Hematologic disease and disorders
Clinical trials for Hematologic disease and disorders explained in plain language.
Never miss a new study
Get alerted when new Hematologic disease and disorders trials appear
Sign up with your email to follow new studies for Hematologic disease and disorders, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene therapy builds Cancer-Killing cells inside you – no lab needed
Disease control Recruiting nowThis early-stage trial tests a new gene therapy called KLN-1010 for people with multiple myeloma that has come back or stopped responding to treatment. Instead of removing cells and engineering them in a lab, this therapy works inside the body to create special immune cells that …
Matched conditions: HEMATOLOGIC DISEASE AND DISORDERS
Phase 1 • Sponsor: Kelonia Therapeutics, Inc. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New approach aims to tame immune storms in Half-Matched transplants
Disease control Recruiting nowThis study tests whether giving the immune-suppressing drug tacrolimus earlier than usual can lower the risk of cytokine release syndrome (CRS), a severe inflammatory reaction, in patients receiving a half-matched stem cell transplant for blood cancer. About 20 adults will receiv…
Matched conditions: HEMATOLOGIC DISEASE AND DISORDERS
Phase 2 • Sponsor: Northside Hospital, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Can immune cell recovery predict transplant success?
Knowledge-focused Recruiting nowThis study follows 100 adults with blood disorders who receive an unrelated cord blood transplant. Researchers will measure levels of γδ T cells—a type of immune cell—in the blood at several time points over the first year. The goal is to see if the pattern of γδ T cell recovery …
Matched conditions: HEMATOLOGIC DISEASE AND DISORDERS
Sponsor: Anhui Provincial Hospital • Aim: Knowledge-focused
Last updated Aug 26, 2026 00:00 UTC
-
New study tracks hidden blood condition to prevent future disease
Knowledge-focused Recruiting nowThis study follows 100 people aged 55 and older who have clonal hematopoiesis (CH) or unexplained low blood counts. Researchers will monitor their health over time, assess risks for heart disease and blood cancers, and provide personalized support. The goal is to create a bluepri…
Matched conditions: HEMATOLOGIC DISEASE AND DISORDERS
Sponsor: Clinical Hub for Interventional Research (CHOIR) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC